Bernard Chevalier

The edge vascular response following implantation of the Absorb everolimus-eluting bioresorbable vascular scaffold and the XIENCE V metallic everolimus-eluting stent. First serial follow-up assessment at six months and two years: insights from the first-in-man ABSORB Cohort B and SPIRIT II trials

• Gogas B,
• Bourantas C,
• Garcia-Garcia H,
• Onuma Y,
• Muramatsu T,
• Farooq V,
• Diletti R,
• van Geuns R-J,
• De Bruyne B,
• Chevalier B,
• Thuesen L,
• Smits P,
• Dudek D,
• Koolen J,
• Windecker S,
• Whitbourn R,
• McClean D,
• Dorange C,
• Miquel-Hebert K,
• Veldhof S,
• Rapoza R,
• Ormiston J,
• Serruys PW

EuroIntervention 2013; 8-online publish-ahead-of-print April 2013

Published ahead of print on April 30, 2013

Impact of CT-guided valve sizing on post-procedural aortic regurgitation in transcatheter aortic valve implantation

• Hayashida K,
• Bouvier E,
• Lefèvre T,
• Hovasse T,
• Morice M-C,
• Chevalier B,
• Romano M,
• Garot P,
• Mylotte D,
• Farge A,
• Donzeau-Gouge P,
• Cormier B

EuroIntervention 2012;8:546-555

Published in Volume 8 Number 5, September 2012

Clinical performance of a drug-eluting stent with a biodegradable polymer in an unselected patient population: the NOBORI 2 study

• Danzi G,
• Chevalier B,
• Urban P,
• Fath-Ordoubadi F,
• Carrié D,
• Wiemer M,
• Serra A,
• Wijns W,
• Kala P,
• Stabile A,
• Ruigomez J,
• Sagic D,
• Laanmets P,
• Strupp G,
• West N,
• Paunovic D

EuroIntervention 2012;8:109-116 publish online ahead of print January 2012

Published in Volume 8 Number 1, May 2012

Unprotected left main stenting with a second-generation drug-eluting stent: one-year outcomes of the LEMAX Pilot study

• Salvatella N,
• Morice M-C,
• Darremont O,
• Tafflet M,
• Garot P,
• Leymarie J,
• Chevalier B,
• Lefèvre T,
• Louvard Y,
• Boudou N,
• Dumonteil N,
• Carrié D

EuroIntervention 2011;7:689-696

Published in Volume 7 Number 6, October 2011

Transfemoral aortic valve implantation: new criteria to predict vascular complications

• Hayashida K,
• Lefèvre T,
• Chevalier B,
• Hovasse T,
• Romano M,
• Garot P,
• Mylotte D,
• Uribe J,
• Farge A,
• Donzeau-Gouge P,
• Bouvier E,
• Cormier B,
• Morice M-C

Published in Volume 7 Supplement M, May 2011

A six-month analysis of quantitative echogenicity of the second generation everolimus-eluting bioresorbable vascular scaffold in relationship with baseline greyscale intravascular ultrasound morphology of the scaffolded plaque

• Brugaletta S,
• Serruys PW,
• Ormiston J,
• Gomez-Lara J,
• Farooq V,
• van Geuns R-J,
• de Bruyne B,
• Dudek D,
• Thuesen L,
• Chevalier B,
• McClean D,
• Windecker S,
• Whitbourn R,
• Veldhof S,
• Miquel-Hebert K,
• Rapoza R,
• van Domburg R,
• Sihan K,
• de Winter S,
• García-García HM,
• Bruining N

Published in Volume 7 Supplement M, May 2011

Angiographic geometric changes of the lumen vessel wall after bioresorbable vascular scaffolds and metallic platform stents at one-year follow-up

• Gomez-Lara J,
• Brugaletta S,
• Farooq V,
• van Geuns R-J,
• de Bruyne B,
• Windecker S,
• McClean D,
• Thuesen L,
• Dudek D,
• Koolen J,
• Whitbourn R,
• Smits P,
• Chevalier B,
• Morel M-A,
• Dorange C,
• Veldhof S,
• Rapoza R,
• García-García HM,
• Ormiston J

Published in Volume 7 Supplement M, May 2011

Bifurcation stenting with a new generation DES: one year clinical outcome in a large cohort of patients

• Chevalier B,
• Morice M-C,
• Tresukosol D,
• Lim V,
• Santoso T,
• Zhang X,
• Pham M,
• Quan Huan D,
• Danzi G

Published in Volume 7 Supplement M, May 2011

Long-term clinical outcome of patients with coronary chronic total occlusion treated with new generation DES

• Chevalier B,
• Sagic D,
• Trani C,
• Tresukosol D,
• Laanmets P,
• Lombardi M,
• Novo Garcia E,
• Hoffmann S,
• Schwacke H,
• Birkemeyer R,
• Hildick-Smith D,
• Neskovic A,
• Stojkovic S,
• Danzi G

Published in Volume 7 Supplement M, May 2011

NOBORI France: comparison with Pan-European and Asian population

• Monsegu J,
• Koning R,
• Rioufol G,
• Unterseeh T,
• Carrié D,
• Darremont O,
• Tresukosol D,
• Lim V,
• Santoso T,
• Chevalier B

Published in Volume 7 Supplement M, May 2011

Off label use of DES with biodegradable polymer at 2 years

• Danzi G,
• Wijns W,
• Barbato E,
• Perisic Z,
• Koning R,
• Kala P,
• Hauptmann K-E,
• Fath-Ordoubadi F,
• Carrié D,
• Chevalier B,
• Morice M-C,
• Kornowski R

Published in Volume 7 Supplement M, May 2011

Head-to-head comparison of Everolimus- vs. Zotarolimus- and Sirolimus-eluting stents: one-year clinical outcomes from the ProEnCy registry

• Richardt G,
• Chevalier B,
• Tijssen J,
• Underwood P,
• Hamm C

Published in Volume 7 Supplement M, May 2011

Effect of paclitaxel elution from reservoirs with bioabsorbable polymer compared to a bare metal stent for the elective percutaneous treatment of de novo coronary stenosis: the EUROSTAR-II randomised clinical trial

• Silber S,
• Gutiérrez-Chico J-L,
• Behrens S,
• Witzenbichler B,
• Wiemer M,
• Hoffmann S,
• Slagboom T,
• Harald D,
• Suryapranata H,
• Nienaber C,
• Chevalier B,
• Serruys PW

EuroIntervention 2011;7:64-73

Published in Volume 7 Number 1, May 2011

Comparison between the first and second generation bioresorbable vascular scaffolds: a six month virtual histology study

• Brugaletta S,
• García-García HM,
• Diletti R,
• Gomez-Lara J,
• Garg S,
• Onuma Y,
• Shin E,
• van Geuns R-J,
• de Bruyne B,
• Dudek D,
• Thuesen L,
• Chevalier B,
• McClean D,
• Windecker S,
• Whitbourn R,
• Dorange C,
• Veldhof S,
• Rapoza R,
• Sudhir K,
• Bruining N,
• Ormiston J,
• Serruys PW

EuroIntervention 2011;6:1110-1116

Published in Volume 6 Number 9, April 2011

Is there a need for dedicated bifurcation devices?

• Lefèvre T,
• Chevalier B,
• Louvard Y

EuroIntervention Supplement (2010) Vol. 6 (Supplement J) J123-J129

Published in Volume 6 Supplement J, December 2010

One-year clinical outcome in patients with acute myocardial infarction treated with new generation of drug-eluting stents: Nobori AMI study

• Fath-Ordoubadi F,
• Metzger J,
• Chevalier B,
• Laanmets P,
• Jagic N,
• Hoffmann S,
• Schoenman G,
• Kornowski R,
• Stabile A,
• Minguez J,
• Aguilar R,
• Ostojic M,
• Danzi G

Published in Volume 6 Supplement H, May 2010

Spirit V single arm study: 2-year clinical follow-up

• Stuteville M,
• Chevalier B

Published in Volume 6 Supplement H, May 2010

Clinical outcomes of chronic total occlusions in NOBORI 2 Study

• Chevalier B,
• Morice M-C,
• Serra A,
• Tresukosol D,
• Lim V,
• Santoso T,
• Zhang X,
• Hung P,
• Do Q,
• Danzi G

Published in Volume 6 Supplement H, May 2010

One-year clinical outcomes of patients with coronary chronic total occlusion lesions treated with a new generation of drug-eluting stents

• Chevalier B,
• Goicolea J,
• Hildick-Smith D,
• Koning R,
• Tresukosol D,
• Manari A,
• Hoffmann S,
• Hauptmann K,
• Perisic Z,
• Darremont O,
• Lim V,
• Aleil B,
• Danzi G

Published in Volume 6 Supplement H, May 2010

Clinical outcomes of bifurcation stenting in NOBORI 2 study

• Morice M-C,
• Chevalier B,
• Tresukosol D,
• Lim V,
• Santoso T,
• Zhang X,
• Hung P,
• Do Q,
• Danzi G

Published in Volume 6 Supplement H, May 2010

Conformability of bioresorbable Everolimus-eluting scaffolds as compared to metal platform stents

• Gomez-Lara J,
• García-García HM,
• Onuma Y,
• Thuesen L,
• Dudek D,
• Garg S,
• de Bruyne B,
• Windecker S,
• Chevalier B,
• Smits P,
• McClean DR,
• Koolen J,
• Whitbourn R,
• Veldhof S,
• Dorange C,
• Ormiston J,
• Serruys PW

Published in Volume 6 Supplement H, May 2010

First clinical report of a large, all comers study with the new generation drug-eluting stent

• Danzi G,
• Wiemer M,
• Koning R,
• Serra A,
• Hauptmann K,
• Kala P,
• Carrié D,
• Fath-Ordoubadi F,
• Goicolea J,
• Wijns W,
• Koolen J,
• Chevalier B

Published in Volume 6 Supplement H, May 2010

Nobori 1 - long term results: 3 years phase 1 & 2 and 4 years phase 1

• Chevalier B,
• Serruys PW,
• Silber S,
• Garcia E,
• Suryapranata H,
• Schuler G,
• Hauptmann K-E,
• Park S,
• Koolen J,
• Wijns W,
• Fath-Ordoubadi F,
• Worthley S,
• Thuesen L

Published in Volume 6 Supplement H, May 2010

Six months clinical outcomes in Nobori-STEMI Study

• Fath-Ordoubadi F,
• Hildick-Smith D,
• Carrier D,
• Laanmets P,
• Guarinos J,
• Jagic N,
• Hoffmann S,
• Monsegu J,
• Chevalier B,
• Danzi G

Published in Volume 5 Supplement E, May 2009

NOBORI 1- Long term results: two years phase 1&2 and three years phase 1

• Chevalier B,
• Silber S,
• Garcia E,
• Wijns W,
• Worthley S,
• Meredith I,
• Suryapranata H,
• Hauptmann K-E,
• Schuler G,
• Thuesen L

Published in Volume 5 Supplement E, May 2009

Meeting report. ESC Forum on Drug Eluting Stents, European Heart House, Nice, 27-28 September 2007

• Daemen J,
• Simoons M,
• Wijns W,
• Bagust A,
• Bos G,
• Bowen J,
• Braunwald E,
• Camenzind E,
• Chevalier B,
• Di Mario C,
• Fajadet J,
• Gitt A,
• Guagliumi G,
• Hillege H,
• James S,
• Jüni P,
• Kastrati A,
• Kloth S,
• Kristensen S,
• Krucoff M,
• Legrand V,
• Pfisterer M,
• Rothman M,
• Serruys PW,
• Silber S,
• Steg P,
• Tariah I,
• Wallentin L,
• Windecker S

EuroInterv.2009;4:427-436

Published in Volume 4 Number 4, January 2009

Systematic primary aspiration in acute myocardial percutaneous intervention: a multicentre randomised controlled trial of the export aspiration catheter

• Chevalier B,
• Gilard M,
• Lang I,
• Commeau P,
• Roosen J,
• Hanssen M,
• Lefèvre T,
• Carrié D,
• Bartorelli A,
• Montalescot G,
• Parikh K

EuroInterv.2008;4:222-228

Published in Volume 4 Number 2, August 2008

One year results of a new in situ length-adjustable stent platform with a biodegradable Biolimus A9 eluting polymer: results of the CUSTOM-II trial

• Stella P,
• Mueller R,
• Pavlakis G,
• de Bruyne B,
• Hauptmann K-E,
• Morice M-C,
• Chevalier B,
• Fajadet J,
• Sievert H,
• Grube E

EuroInterv.2008;4:200-207

Published in Volume 4 Number 2, August 2008

Constructing a checklist for the prevention of complications during percutaneous coronary intervention

• Van de Walle S,
• Lerman A,
• Chevalier B,
• Sabate M,
• Aminian A,
• Roguelov C,
• Eeckhout E

EuroInterv.2008;4:181-192

Published in Volume 4 Number 2, August 2008

Ischaemic events and bleeding in patients undergoing percutaneous coronary intervention with concomitant bivalirudin treatment

• Madsen JK,
• Chevalier B,
• Darius H,
• Rutsch W,
• Wójcik J,
• Schneider S,
• Allikmets K

EuroInterv.2008;3:610-616

Published in Volume 3 Number 5, March 2008

First-in-human feasibility and safety study of a true bifurcated stent for the treatment of bifurcation coronary artery lesions (DBS stent): six month angiographic results and five year clinical follow-up

• Dibie A,
• Chevalier B,
• Guyon P,
• Fajadet J,
• Lefèvre T,
• Slama M,
• Royer T,
• Glatt B,
• Philippe F,
• Laborde F,
• Larrazet F

EuroInterv.2008;3:558-565

Published in Volume 3 Number 5, March 2008

Two-year clinical results of a polymer-free, paclitaxel-eluting stent: the ELUTES trial

• Swanson N,
• de Scheerder I,
• Chevalier B,
• Camenzind E,
• Carver A,
• Gershlick A

EuroInterv.2007;3:109-112

Published in Volume 3 Number 1, May 2007

European perspective in the recanalisation of Chronic Total Occlusions (CTO): consensus document from the EuroCTO Club

• Di Mario C,
• Werner G,
• Sianos G,
• Galassi A,
• Büttner J,
• Dudek D,
• Chevalier B,
• Lefèvre T,
• Schofer J,
• Koolen J,
• Sievert H,
• Reimers B,
• Fajadet J,
• Colombo A,
• Gershlick A,
• Serruys PW,
• Reifart N

EuroInterv.2007;3:30-43

Published in Volume 3 Number 1, May 2007

Randomised comparison of Nobori™, biolimus A9-eluting coronary stent with a Taxus®, paclitaxel-eluting coronary stent in patients with stenosis in native coronary arteries: the Nobori 1 trial

• Chevalier B,
• Serruys PW,
• Silber S,
• Garcia E,
• Suryapranata H,
• Hauptmann K-E,
• Wijns W,
• Schuler G,
• Fath-Ordoubadi F,
• Worthley S,
• Thuesen L,
• Meredith I,
• Bressers M,
• Nagai H,
• Paunovic D

EuroInterv.2007;2:426-434

Published in Volume 2 Number 4, February 2007